VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
46,870MODERNA
532GLAXOSMITHKLINE BIOLOGICALS
353PFIZER\BIONTECH
231MERCK & CO. INC.
221UNKNOWN MANUFACTURER
62SEQIRUS, INC.
25DYNAVAX TECHNOLOGIES CORPORATION
13EMERGENT BIOSOLUTIONS
12SANOFI PASTEUR
9NOVARTIS VACCINES AND DIAGNOSTICS
5PFIZER\WYETH
5PAXVAX
2TEVA PHARMACEUTICALS
2PROTEIN SCIENCES CORPORATION
1BERNA BIOTECH, LTD.
1INTERCELL AG
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL1,906
1,575
289
IMM209286
252
236
229
s029456178
171
UT7065MA166
155
149
145
S034636133
107
U62828AA103
100
98
P10025327596
U6737AA85
UJ446AA79
78
78
59
57
4BH3254
4F47253
52
27656352
50
PP9L548
49TM346
42
40
38
MENVEO38
4F47237
R1B252M36
34
C5763AA30
93362229
25
300057A24
UNK24
22
CW311621
18
17
15
UH894AB15
3Y7NL12
R1B743M12
EJ168611
el128410
10
10
10
9
ARBA141A9
UNK9
8
UNK8
8
1F4EB8
Unknown7
7
No batch number6
5
5
UJ090AA5
5
5
4
4
4
UNK4
JEV18K95E4
UNK3
A115A3
Z127A3
3
3333324181073
2
2
2
TAR352
1
1
1
1
1
A739081
1
1
1
1
1
037K20A68,542
EL128447,700
133

Incidents per State

State Total
15,185
CA14,096
NY7,507
TX7,196
FL6,939
IN5,527
PA4,560
IL4,179
OH4,054
AZ3,856
MI3,771
NJ3,411
MA3,278
VA3,208
NC3,114
WA3,034
GA2,864
MD2,652
MN2,534
CO2,532
WI2,457
MO2,029
OR1,943
TN1,715
CT1,693
KY1,603
OK1,226
AL1,201
KS1,162
IA1,157
SC1,106
NM1,065
UT973
AR951
LA945
NE829
NV797
ME795
MT789
NH756
ID674
AK661
WV661
PR650
MS585
HI536
RI510
VT441
SD361
ND356
DE350
DC239
WY209
GU32
AS16
VI13
MP9
MH3
FM2
QM1
XB1

ID: 1423667
Sex: F
Age: 41
State:

Vax Date: 01/11/2021
Onset Date: 01/11/2021
Rec V Date: 01/13/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Sedation, Myalgia, Arthralgia, chills, fatigue,poor concentration, site pain Narrative: Last night cold chills, cold chills today, severe fatigue (difficult to stay awake), difficult to concentrate (I do not feel like myself), generalized muscle pain and pain at the injection site

Other Meds:

Current Illness:

ID: 1423668
Sex: F
Age: 53
State:

Vax Date: 12/31/2020
Onset Date: 01/12/2021
Rec V Date: 01/13/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Rash secondary cellulitis Narrative:

Other Meds:

Current Illness:

ID: 1423669
Sex: F
Age: 31
State:

Vax Date: 01/09/2021
Onset Date: 01/09/2021
Rec V Date: 01/13/2021
Hospital:

Lab Data:

Allergies:

Symptoms: UrticariaPruritus Narrative: Approx. 6 hours after receiving my 2nd dose on 1/9/2021, I developed hives on my face and neck. Symptoms resolved after taking Benadryl.

Other Meds:

Current Illness:

ID: 1423670
Sex: F
Age: 49
State:

Vax Date: 12/22/2020
Onset Date: 12/24/2020
Rec V Date: 01/13/2021
Hospital:

Lab Data:

Allergies:

Symptoms: SkinRash Narrative: Employee reported generalized facial rash noted on 12/24/20, 2 days post vaccine denies itching, swelling or pain and totally resolved by 12/26/20.

Other Meds:

Current Illness:

ID: 1423671
Sex: M
Age: 50
State:

Vax Date: 01/11/2021
Onset Date: 01/11/2021
Rec V Date: 01/13/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Headache, Myalgia, Arthralgia, Fatigue and Chills but no elevated temperature. Narrative:

Other Meds:

Current Illness:

ID: 1423672
Sex: F
Age: 41
State:

Vax Date: 01/09/2021
Onset Date: 01/09/2021
Rec V Date: 01/13/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Headache fatigue Narrative: missed one day of work due to headache and fatigue following second dose

Other Meds:

Current Illness:

ID: 1423673
Sex: M
Age: 42
State:

Vax Date: 01/08/2021
Onset Date: 01/09/2021
Rec V Date: 01/13/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Headache, Arthralgia & Fever Narrative:

Other Meds:

Current Illness:

ID: 1423674
Sex: F
Age: 46
State:

Vax Date: 01/08/2021
Onset Date: 01/09/2021
Rec V Date: 01/13/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Headache, Myalgia, Arthralgia, Fever, CoughWheeze, Rash, Chills, arm soreness. Narrative:

Other Meds:

Current Illness:

ID: 1423675
Sex: F
Age: 24
State:

Vax Date: 01/05/2021
Onset Date: 01/12/2021
Rec V Date: 01/13/2021
Hospital:

Lab Data:

Allergies:

Symptoms: SkinRash Narrative: Employee developed a quarter sized itchy rash at the injection site

Other Meds:

Current Illness:

ID: 1423676
Sex: F
Age: 32
State:

Vax Date: 01/12/2021
Onset Date: 01/12/2021
Rec V Date: 01/13/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Tachycardia Jittery, Flushing Narrative: Employee was vaccinated with Moderna COVID vaccine at approx 1130am. Within 10 minutes she reported a "flushing sensation", "feeling jittery" and was tachycardic with initial pulse approx 140. She was A&Ox3. EMS called for evaluation.

Other Meds:

Current Illness:

ID: 1423677
Sex: M
Age: 50
State:

Vax Date: 01/05/2021
Onset Date: 01/06/2021
Rec V Date: 01/13/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Headache, Myalgia & Nausea Vomiting Narrative:

Other Meds:

Current Illness:

ID: 1423678
Sex: F
Age: 31
State:

Vax Date: 12/30/2020
Onset Date: 01/01/2021
Rec V Date: 01/13/2021
Hospital:

Lab Data:

Allergies:

Symptoms: SkinRash Narrative: rash that has spread from arm pits down torso

Other Meds:

Current Illness:

ID: 1423679
Sex: M
Age: 71
State:

Vax Date: 01/12/2021
Onset Date: 01/12/2021
Rec V Date: 01/13/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Dizziness Narrative: After patient was dismissed from observation after receiving Pfizer Vaccine. He walked out to go to his car with wife at side. when got to the patient garage elevators, he reported to the staff he felt dizzy. The staff then reported to the patient gym to inform a nurse. Nurse assessed patient and took vitals at 10:45 BP: 110/60 P: 55 T: 97.3. Patient reported he felt fine and declined to elevate care to emergency room. Patient condition resolved and the nurse provided a wheelchair for his wife to transport him to his car for safety.

Other Meds:

Current Illness:

ID: 1884721
Sex: M
Age: 50
State:

Vax Date: 01/12/2021
Onset Date:
Rec V Date: 01/13/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Headache, Nausea Vomiting, fatigue

Other Meds: dietary supplements, or herbal remedies being taken at time of vaccination

Current Illness:

ID: 1884722
Sex: F
Age: 65
State:

Vax Date: 01/09/2021
Onset Date: 01/09/2021
Rec V Date: 01/13/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Myalgia, Fever, Chills Narrative:

Other Meds:

Current Illness:

ID: 1884723
Sex: F
Age: 42
State:

Vax Date: 12/30/2020
Onset Date: 01/06/2021
Rec V Date: 01/13/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Pain, Erythema/enduration at injection site Narrative:

Other Meds:

Current Illness:

ID: 1885980
Sex: F
Age: 25
State:

Vax Date: 01/11/2021
Onset Date: 01/11/2021
Rec V Date: 01/13/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Headache, Arthralgia, Nausea Vomiting, weakness, fatigue

Other Meds:

Current Illness:

ID: 1885981
Sex: F
Age: 45
State:

Vax Date: 12/24/2020
Onset Date: 12/24/2020
Rec V Date: 01/13/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Confusion, Headache, Myalgia, NUMBNESS ABOVE LIP, BRUISE ON ARM, ITCHING Narrative:

Other Meds:

Current Illness:

ID: 1885982
Sex: F
Age: 41
State:

Vax Date: 01/11/2021
Onset Date: 01/11/2021
Rec V Date: 01/13/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Headache, Diarrhea, left arm numbness to pibky and ring finger Narrative:

Other Meds:

Current Illness:

ID: 1885983
Sex: F
Age: 48
State:

Vax Date: 01/12/2021
Onset Date: 01/09/2021
Rec V Date: 01/13/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Myalgia, Arthralgia, Fever, fatigue Narrative: on Saturday 1/9/21, had fever of 100.3, muscle and joint aches and fatigue; Sunday 1/10/21-milder joint and muscke aches, temperature between 98.6 and 99.6 fluctuating thru the day, Monday 1/11/21- temperature WNL (98.6), still some fatigue- able to work though

Other Meds:

Current Illness:

ID: 1885984
Sex: M
Age: 38
State:

Vax Date: 01/11/2021
Onset Date: 01/12/2021
Rec V Date: 01/13/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Myalgia, Arthralgia, Fatigue, Muscle Soreness, no Appetitie Narrative:

Other Meds:

Current Illness:

ID: 1889307
Sex: M
Age: 37
State:

Vax Date: 01/06/2021
Onset Date: 01/08/2021
Rec V Date: 01/13/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Headache & NauseaVomiting Narrative:

Other Meds:

Current Illness:

ID: 1889308
Sex: M
Age: 62
State:

Vax Date: 01/12/2021
Onset Date: 01/12/2021
Rec V Date: 01/13/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Numbness and tingling to Bil upper and lower extremities. Narrative: pt has a hx of neuropathy and states he feels that it came on after vaccination.

Other Meds:

Current Illness:

ID: 0942561
Sex: U
Age:
State: FL

Vax Date:
Onset Date:
Rec V Date: 01/14/2021
Hospital:

Lab Data:

Allergies:

Symptoms: no additional AE; temperature excursion; This non-valid spontaneous report was received from a registered medical assistant and refers to an unknown patient of unknown demographics. The patient's pertinent medical history, concomitant medications and drug reactions or allergies were unknown. On an unknown date in 2020, the patient was vaccinated with an improperly stored pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) pre-filled syringe, injection, lot # T028093, expiration date 24-APR-2022 (exact dose, anatomical location and route of administration were not reported) for prophylaxis (storage error). The administered dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) experienced a temperature excursion of 46.6 degrees Fahrenheit (F) for 45 minutes. Previous temperature excursions included 46.4 degrees F for 15 minutes on 29-SEP-2020 and 47.4 degrees F on 02-NOV-2020. The temperatures were captured with the use of a digital data logger. There were no additional adverse events reported. This report was considered to be non-valid due to lack of patient identifiers. combinationproductreport: Yes; brandname: PNEUMOVAX23 SYRINGE (DEVICE); commondevicename: Pneumococcal Vaccine, Polyvalent (23-valent); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: T028093; expirationdate: 24-APR-2022; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability

Other Meds: PNEUMOVAX 23 SYRINGE

Current Illness:

ID: 0942562
Sex: F
Age:
State: IL

Vax Date:
Onset Date:
Rec V Date: 01/14/2021
Hospital:

Lab Data:

Allergies:

Symptoms: she had high fever; her arm was swollen at the injection site; she was vomiting; she was kinda sick; This spontaneous report was received from a consumer reporting on herself, via Pfizer, a female patient of unknown age. Concomitant medications included atorvastatin calcium (LIPITOR). Information regarding the patient's medical history or concurrent conditions was not provided. On an unknown date the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) for prophylaxis (dose, route of administration, vaccination scheme frequency, anatomical location, lot number and expiration date were not reported). On the same day, several hours later, the patient had a high fever, her arm was swollen at the injection site, she was vomiting, she was kind of sick (pyrexia, vaccination site swelling, vomiting and illness). The outcome of the events pyrexia, illness, vomiting and vaccination site swelling and the causal relationship between the event and pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) vaccination were not reported.

Other Meds: LIPITOR

Current Illness:

ID: 0942563
Sex: U
Age: 1
State: IL

Vax Date: 11/12/2020
Onset Date: 11/12/2020
Rec V Date: 01/14/2021
Hospital:

Lab Data:

Allergies:

Symptoms: No other adverse event details available; incorrect product storage/vaccine had a temperature excursion of -13.3 degrees Celsius; This spontaneous report was received from a registered nurse concerning a 13-month-old patient of unknown gender. The patient's medical history, historical drugs, allergies, concurrent conditions and concomitant therapies were not provided. On 12-NOV-2020, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (Oka/Merck) (VARIVAX), 0.5 milliliter (ml) for prophylaxis, lot number T017688 and expiration date 21-MAY-2022 (strength, route of administration and anatomical site of vaccination were not provided). No additional adverse event (AE) details were available at the time of report.. The administered vaccine had a temperature excursion of -13.3 degrees Celsius (?C) for 4 hours and 15 minutes on an unspecified date, and the data was recorded by a digital data logger. It was also reported there was not a previous temperature excursion. This is one of several reports received from the same reporter.

Other Meds:

Current Illness:

ID: 0942564
Sex: U
Age: 1
State: FL

Vax Date: 01/04/2021
Onset Date: 01/04/2021
Rec V Date: 01/14/2021
Hospital:

Lab Data:

Allergies:

Symptoms: VARlVAX was improperly stored and administered; This spontaneous report was received from other health professional referring to a 1-year-old patient. Information regarding the patient's pertinent medical history, historical drugs, concurrent conditions, concomitant therapies, and previous drug reactions or allergies was not reported. On 04-JAN-2021, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck) (VARIVAX) lot # T021824, expiration date 25-JUN-2022 for prophylaxis (dose, vaccination scheme frequency, route of administration and anatomical site of vaccination were not reported). The vaccine was stored in a temperature of 16.1 degree Fahrenheit (?F) for 1 hour and 45 minutes as recorded by a data logger. There was no previous temperature excursion reported.

Other Meds:

Current Illness:

ID: 0942565
Sex: U
Age: 0
State: KS

Vax Date: 01/04/2020
Onset Date: 01/04/2020
Rec V Date: 01/14/2021
Hospital:

Lab Data:

Allergies:

Symptoms: No additional adverse events reported; A dose of MMRlI and VARIVAX was given to a patient during a temperature excursion; This spontaneous report was received from a medical assistant concerning to a 3-days-old patient (discrepant information) of an unknown gender. The patient's medical history, historical drugs, allergies, concurrent conditions and concomitant therapies were not provided. On 04-JAN-2020 (discrepant information), the patient was vaccinated with improperly stored doses of measles (+) mumps (+) rubella (wistar ra 27-3) virus vaccine, live (rHA) (M-M-R II), 0.5 milliliter (ml) for prophylaxis, lot number reported as S029456 and expiration date as 19-SEP-2021 (formulation, strength, vaccination scheme, route of administration and anatomical site of vaccination were not provided); and varicella virus vaccine live (oka/merck) (VARIVAX), 0.5 milliliter for prophylaxis, lot number reported as T020650 and expiration date as 16-JUN-2022 (formulation, strength, vaccination scheme, route of administration and anatomical site of vaccination were not provided). No additional adverse events were reported. The administered vaccines had a temperature excursion of 5.6 degrees Celsius (?C) for a time frame of 16 hours and 20 minutes later found supported. There was not a digital data logger involved. It was also reported there was not a previous temperature excursion.

Other Meds:

Current Illness:

ID: 0942566
Sex: U
Age:
State: NY

Vax Date: 12/14/2020
Onset Date: 12/14/2020
Rec V Date: 01/14/2021
Hospital:

Lab Data:

Allergies:

Symptoms: No additional AE; doses were administered following the excursion; This spontaneous report was received from a physician referring to a 4-year-old patient. Information regarding the patient's pertinent medical history, historical drugs, concurrent conditions, concomitant therapies, and previous drug reactions or allergies was not reported. On 14-DEC-2020, the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live, recombinant human albumin (rha) (PROQUAD) lot # T021642, expiration date 21-DEC-2021, at a dose of 0.5 milliliter for prophylaxis (vaccination scheme frequency, route of administration and anatomical site of vaccination were not reported). The vaccine was stored in a temperature of 16.2 degree Fahrenheit (?F) for 1 hour 14 minutes as recorded by a data logger. There was no previous temperature excursion reported.

Other Meds:

Current Illness:

ID: 0942567
Sex: U
Age: 31
State: IL

Vax Date: 01/06/2021
Onset Date: 01/06/2021
Rec V Date: 01/14/2021
Hospital:

Lab Data:

Allergies:

Symptoms: dose of MMRlI was administered to a patient yesterday 01/06/2021 (Expiration Date: 10/24/2020); No additional adverse events reported; This spontaneous report was received from a pharmacist, referring to a 31-year-old patient of unknown gender. Information regarding the patient's medical history, concurrent conditions or concomitant medications was unknown. On 06-JAN-2021 the patient was vaccinated with an expired dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) 0.5 milliliter (strength, route of administration, and anatomical location were not reported; lot number R030812 and expiration date 24-OCT-2020). No additional adverse events reported. The outcome of expired dose administered was unknown.

Other Meds:

Current Illness:

ID: 0942568
Sex: U
Age:
State: MI

Vax Date:
Onset Date: 01/06/2021
Rec V Date: 01/14/2021
Hospital:

Lab Data:

Allergies:

Symptoms: no adverse event; Varivax was administered to a patient after improper storage; This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant therapies were not provided. On an unknown date, the patient was vaccinated with varicella virus vaccine live (oka/merck)(VARIVAX) (dose, route, and anatomical location unknown) lot # T017686, expiration date 21-MAY-2022, 1 dosage form, for prophylaxis. On 06-JAN-2021, it was noticed the patient had been vaccinated with an inappropriately stored varicella virus vaccine live (oka/merck)(VARIVAX) vaccine. The vaccine was stored at a temperature of -12?C for 11 hours and 10 min. Also, there was a previous temperature excursion of -14?C to 10?C for 2 hours and 30 minutes. The error was noticed due to a data logger. The patient did not have an adverse event.

Other Meds:

Current Illness:

ID: 0942569
Sex: U
Age:
State: OK

Vax Date: 01/28/2014
Onset Date:
Rec V Date: 01/14/2021
Hospital:

Lab Data:

Allergies:

Symptoms: rheumatoid arthritis; ganglion cysts; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a patient of unknown age and gender. No information was provided regarding medical history, concurrent conditions, or concomitant medications. On or about 28-JAN-2014, the patient was vaccinated (inoculated) with zoster vaccine live (ZOSTAVAX) (lot#, expiration date, dose, dose# and route not specified) for the long-term prevention of shingles and zoster-related conditions. Subsequently, the patient was treated by a provider for the following injuries resulting from the patient's zoster vaccine live (ZOSTAVAX) use: rheumatoid arthritis, and ganglion cysts (synovial cyst). The patient claimed damages as result of injury to themselves, and economic losses.The outcome of the events was not provided. Therefore, the causality for the events was related to zoster vaccine live (ZOSTAVAX). Upon internal review, the event of rheumatoid arthritis was considered to be medically significant.

Other Meds:

Current Illness:

ID: 0942571
Sex: U
Age:
State: MI

Vax Date: 08/13/2012
Onset Date:
Rec V Date: 01/14/2021
Hospital:

Lab Data:

Allergies:

Symptoms: congestive heart failure; rashes; shortness of breath; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a patient of unknown age and gender. No information was provided regarding medical history, concurrent conditions, or concomitant medications. On or about 13-AUG-2012, the patient was vaccinated (inoculated) with zoster vaccine live (ZOSTAVAX) (lot#, expiration date, dose, dose# and route not specified) for the long-term prevention of shingles and zoster-related conditions. Subsequently, the patient was treated by a provider for the following injuries resulting from the patient's zoster vaccine live (ZOSTAVAX) use: rashes, shortness of breath (dyspnea), and congestive heart failure (cardiac failure congestive). The patient claimed damages as result of injury to themselves, and economic losses.The outcome of the events was not provided. Therefore, the causality for the events was related to zoster vaccine live (ZOSTAVAX). Upon internal review, the event of cardiac failure congestive was considered to be medically significant.

Other Meds:

Current Illness:

ID: 0942572
Sex: U
Age:
State: CA

Vax Date: 10/28/2020
Onset Date: 11/24/2020
Rec V Date: 01/14/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Received the first dose of Heplisav-B, then received 2nd dose with Engerix; Initial Report Received on 24-Nov-2020 A registered nurse reported that a 44-year-old male (race and ethnicity not provided) received HEPLISAV-B (hepatitis B vaccine) for the first dose of hepatitis B immunization and received ENGERIX-B as the second dose. The patient has no reported know drug allergies. No concomitant medications were reported. On 28-Oct-2020, the first dose of HEPLISAV-B (Lot # 933837, expiration date 08-May-2021, Serial # 375853594193) was administered to the left deltoid. On 24-Nov-2020, the second dose of a hepatitis B vaccine, Engerix-B (Lot # 5L27A, expiration date 11-Feb-2022), was administered to the left deltoid. At the time of report, no adverse reactions to either injections had been noted. Company Comment: The company assessed the event as non-serious.; Sender's Comments: The company assessed the event as non-serious.

Other Meds: Engerix b

Current Illness:

ID: 0942573
Sex: U
Age:
State: WI

Vax Date: 10/08/2020
Onset Date: 11/19/2020
Rec V Date: 01/14/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Heplisav-B given for first dose, Engerix-B was given for second dose; Initial Report Received on 04-Dec-2020 A pharmacy manager reported that a 63 year-old male (race and ethnicity not provided) received HEPLISAV-B (hepatitis B vaccine) for the first dose of hepatitis B immunization and received ENGERIX-B for the second dose. No medical history included penicillin allergy. No concomitant medications were reported. On 08-Oct-2020, the patient received the first dose of HEPLISAV-B (Lot # 934259, expiration date 25-Sep-2021 and NDC # not reported) to the left deltoid at the pharmacy. On onset 19-Nov-2020, the patient was given ENGERIX-B (Lot # 5NY2K, expiration date 29-May-2022 and MDC # not reported) to the right deltoid at his doctor's office. The patient did not report any adverse reactions to either vaccination. No additional information was reported. Company Comment: The company assessed the event as non-serious.; Sender's Comments: The company assessed the event as non-serious.

Other Meds: Engerix b

Current Illness:

ID: 0942574
Sex: U
Age: 0
State: MA

Vax Date: 12/09/2020
Onset Date: 12/09/2020
Rec V Date: 01/14/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Administered to Newborn; Vaccine administered at inappropriate site; Initial Report Received on 15-Dec-2020 A pharmacist reported that a newborn female (race and ethnicity not provided) received HEPLISAV-B (hepatitis B vaccine) for hepatitis B immunization. No medical history or known drug allergies were reported. No concomitant medications were reported. On 09-Dec-2020, on the day of birth, the patient received a dose of HEPLISAV-B (Lot # 933839, expiration date 28-Feb-2021 and NDC # not reported) to the right thigh. At the time of report, no adverse reactions had been reported. No additional information was reported. Company Comment: The company assessed the events as non-serious.; Sender's Comments: The company assessed the events as non-serious.

Other Meds:

Current Illness:

ID: 0942575
Sex: U
Age: 0
State: MA

Vax Date: 12/09/2020
Onset Date: 12/09/2020
Rec V Date: 01/14/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Administered to Newborn; Vaccine administered at inappropriate site; Initial Report Received on 15-Dec-2020 A pharmacist reported that a newborn female patient (race and ethnicity not provided) received HEPLISAV-B (hepatitis B vaccine) for hepatitis B immunization. No medical history or known drug allergies were reported. No concomitant medications were reported. On 09-Dec-2020, on the day of birth, the patient received a dose of HEPLISAV-B (Lot # 933839, expiration date 28-Feb-2021 and NDC # not reported) to the left thigh. At the time of report, no adverse reactions had been reported. No additional information was reported. Company Comment: The company assessed the event as non-serious.; Sender's Comments: The company assessed the event as non-serious.

Other Meds:

Current Illness:

ID: 0942576
Sex: U
Age: 60
State: OH

Vax Date: 11/11/2020
Onset Date: 12/30/2020
Rec V Date: 01/14/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Received Engerix-B for Second Injection; Initial Report Received on 31-Dec-2020 A registered nurse, reported that that a 60-year-old female, received HEPLISAV-B for hepatitis B immunization. The patient has a medical history significant for allergies to Demerol (meperidine), scopolamine patches, sulfa, contrast dye, cats, dogs, dust mites, mold, ragweed trees, weeds and sunflower seeds. On 11-Nov-2020, the patient received dose 1 of HEPLISAV-B in the left deltoid (Lot #934598, expiration date 25-Feb-2022, serial number not available). On 30-Dec-2020, the patient received dose 2 of a hepatitis B vaccine but was administered Engerix-B (Lot # and expiration date not available). The patient reported no adverse reactions to either injection. Company Comment: The company assessed the event as non-serious.; Sender's Comments: The company assessed the event as non-serious.

Other Meds:

Current Illness:

ID: 0942577
Sex: M
Age:
State: OH

Vax Date: 12/29/2020
Onset Date: 12/29/2020
Rec V Date: 01/14/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Given a first dose of the Moderna vaccine of 1ml instead of .5 ml; A spontaneous report was received from a pharmacist concerning a patient who received Moderna's COVID-19 vaccine (mRNA-1273) and was given a first dose of the Moderna vaccine of 1 mL instead of 0.5 mL. The patient's medical history was not provided. No relevant concomitant medications were reported. The patient received their first of two planned doses of mRNA-1273 on 29 Dec 2020 intramuscularly for prophylaxis of COVID-19 infection. During the administration, the pharmacist stated that the patient was given a first dose of the vaccine of 1.0 ml instead of 0.5 ml. Treatment information was not provided. Action taken with mRNA-1273 in response to the event was not reported. The outcome of event was not reported.; Reporter's Comments: This case concerns a male patient who received their first of two planned doses of mRNA-1273 (Lot 011L20A), reporting Incorrect dosage administered without any associated adverse events.

Other Meds:

Current Illness:

ID: 0942578
Sex: F
Age: 52
State: VA

Vax Date: 12/23/2020
Onset Date: 12/23/2020
Rec V Date: 01/14/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Throat tightness; not feeling well; Upper chest pressure; A spontaneous report was received from a pharmacist concerning a 52-year-old, female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced throat tightness, upper chest pressure and was not feeling well. The patient did not have any relevant medical history. The patient denied any previous history of adverse reactions to vaccines. No relevant concomitant medications were reported. On 23 Dec 2020 at 09:40 am, approximately five minutes prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot number: 039K20A) intramuscularly in the arm for prophylaxis of COVID-19 infection. On 23 Dec 2020 at 9:45 am, the patient experienced throat tightness and not feeling well. The patient was pale and hypertensive. She was carried on a stretcher and placed on oxygen. Rapid response team was called in and treatment with intravenous (iv) fluids including iv push of famotidine at a dose of 20 mg was initiated. Patient was transported to the Emergency Department (ED) for further evaluation. Additionally, the patient received iv treatment with methylprednisolone succinate at a dose 125 mg and diphenhydramine at a dose of 25 mg. Throat tightness and upper chest pressure were reported to be relieved. The patient was discharged with prescriptions for oral prednisone, famotidine, and diphenhydramine to be taken as needed for recurrent symptoms. Action taken with mRNA-1273 in response to the events of throat tightness, upper chest pressure, and not feeling well was not reported. The events, throat tightness, upper chest pressure, and not feeling well were considered resolved on an unknown date.; Reporter's Comments: This case concerns a 52-year-old, female subject who received their first of two planned doses of mRNA-1273 (Lot 039K20A), experienced the unexpected events of not feeling well; upper chest pressure and not feeling well. The onset of events occurred 5 min after the first dose of vaccine administration. The reporter causality assessment for the events was not provided. Due to the temporal association between the events and the administration of vaccine, a causal relationship cannot be excluded, and the events are assessed as possibly related to vaccine.

Other Meds:

Current Illness:

ID: 0942579
Sex: M
Age:
State: TX

Vax Date: 12/27/2020
Onset Date: 12/27/2020
Rec V Date: 01/14/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Some of the liquid came out of arm when they removed the needle after vaccine administration; Did not have any reaction on the skin that was exposed to the vaccine; A report was received from a nurse concerning male patient of unknown age who received Moderna's COVID-19 vaccine and experienced some of the liquid came out of arm when they removed the needle after vaccine administration and did not have any reaction on the skin that was exposed to the vaccine. The patient's medical history was not provided. No relevant concomitant medications were reported. The patient received their first of two planned doses of mRNA-1273 on 27 Dec 2020. On 27 Dec 2020, just prior to onset of the events, the patient received their first of the two planned doses of mRNA-1273 (Lot number: 037K20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection. On 27 Dec 2020, the reporter stated that some of the liquid came out of the arm when they removed the needle after administration of the vaccine. It was reported that the patient did not have any reaction on the skin that was exposed to the vaccine. No treatment information was provided. Action taken with mRNA-1273 in response to the events was not reported. The events, some of the liquid came out of arm when they removed the needle after vaccine administration and did not have any reaction on the skin that was exposed to the vaccine, were considered resolved on 27 Dec 2020.; Reporter's Comments: This case concerns a male patient who received their first of two planned doses of mRNA-1273 (Lot 037K20A), reporting Incomplete dose administered and exposure via skin contact without any associated adverse events. Both the events occurred same day after the first dose of Moderna COVID-19 Vaccine. The reporter did not provide the causality assessment for the events.

Other Meds:

Current Illness:

ID: 0942580
Sex: F
Age:
State: AZ

Vax Date: 12/28/2020
Onset Date: 12/28/2020
Rec V Date: 01/14/2021
Hospital:

Lab Data: Test Date: 20201228; Test Name: Blood pressure; Result Unstructured Data: No units provided; Test Date: 20201228; Test Name: Temperature; Result Unstructured Data: ?F

Allergies:

Symptoms: Rigidity all over; All muscles were clenched up; BP was 170; Heart rate elevated; A spontaneous report was received from a pharmacist concerning a patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced rigidity all over, all muscles were clenched up, BP was 170, and heart rate elevated. The patient's medical history, as provided by the reporter, was unremarkable with no history of allergies or seizures/epilepsy. No relevant concomitant medications were reported. On 28 Dec 2020, ten minutes prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 intramuscularly in the left deltoid for prophylaxis of COVID-19 infection. On 28 Dec 2020, ten minutes after vaccination, the patient had rigidity all over and all her muscles were noted to be clenched up. There was no loss of consciousness and the patient claimed that she was still able to hear the people around her. Her blood pressure at the time was 170 and her heart rate was noted to be elevated. Her temperature was 98 degree Fahrenheit. Treatment for the event included oral diphenhydramine which caused her condition to subside. After an unspecified period of time, the rigidity recurred and the patient was taken to the emergency room. Action taken with mRNA-1273 in response to the events was not reported. The outcome of the events, rigidity all over, all muscles were clenched up, BP was 170, and heart rate elevated were not reported.; Reporter's Comments: This case concerns a female patient who received their first of two planned doses of mRNA-1273 (Lot unknown), and who experienced the serious unlisted events of Muscle rigidity and Muscle tightness and the non-serious unlisted events of BP was 170 and heart rate elevated. The events occurred 10 minutes after vaccination and treatment with oral diphenhydramine was administered. Based on temporal association between the use of the product and the onset of events, a causal relationship cannot be excluded and the events are considered possibly related to the vaccine.

Other Meds:

Current Illness:

ID: 0942581
Sex: F
Age: 55
State: CT

Vax Date: 12/26/2020
Onset Date: 12/26/2020
Rec V Date: 01/14/2021
Hospital:

Lab Data:

Allergies:

Symptoms: During vaccination, some vaccine leaked out; Nurse said she drew up more than the recommended dose, to allow for leak; Pain in injection site and tenderness; A spontaneous report was received from a physician who was a 55 year old, female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced during vaccination, some vaccine leaked out; nurse said she drew up more than the recommended dose, to allow for leak; and pain in injection site and tenderness. The patient's medical history was not provided. Concomitant product use was not provided. On 26 Dec 2020, the patient received her first of two planned doses of mRNA-1273 (Lot number: 039K20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection. On 26 Dec 2020, during the vaccination, some vaccine leaked out, but the administering nurse said she drew up more than the recommended dose, to allow for the leak. The patient believed she received 0.45 - 0.48 ml of the dose. She also experienced pain in the injection site and tenderness and the symptoms went away the same day. No treatment was reported. Action taken with mRNA-1273 in response to the events was not reported. The events, during vaccination, some vaccine leaked out; nurse said she drew up more than the recommended dose, to allow for leak; and pain in injection site and tenderness, were considered resolved on 26 Dec 2020.; Reporter's Comments: This report refers to a case of incorrect dose administered and product selection error for mRNA-1273 (Lot number: 039K20A) and concerns a 55 year-old, female patient, who experienced the event of injection site pain. The event occurred the same day after the first dose of mRNA-1273 vaccine administration. Based on the current available information and temporal association between the use of the product and the start of the event, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 0942582
Sex: F
Age: 44
State: TX

Vax Date: 12/29/2020
Onset Date: 12/29/2020
Rec V Date: 01/14/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Some dose came out of needle attached to syringe when injecting; A spontaneous report was received from a nurse concerning a 44-year-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced the event, some dose came out of the needle attached to the syringe while injecting the vaccine. The patient's medical history was not provided. Concomitant product use was not reported. On 29 Dec 2020, the patient received their first of two planned doses of mRNA-1273 (Lot number: 037K20A) intramuscularly in the left deltoid for prophylaxis of COVID-19 infection. On 29 Dec 2020, while the vaccine was being administered, some dose came out of the needle attached to the syringe. It was unknown how much vaccine was administered or how much was spilled. No treatment information was provided. Action taken with mRNA-1273 in response to the events was not provided. The outcome of the event, some dose came out of the needle attached to the syringe while injecting the vaccine, was considered resolved on 29 Dec 2020.; Reporter's Comments: This report refers to a case of 44- year-old female patient who experienced event of administered, some dose came out of the needle attached to the syringe for mRNA-1273, lot # 037K20A. There were no reported AEs associated with this case of some dose came out of the needle attached to the syringe .

Other Meds:

Current Illness:

ID: 0942583
Sex: F
Age: 45
State: CT

Vax Date: 12/29/2020
Onset Date: 12/29/2020
Rec V Date: 01/14/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Some of the vaccine leaked out and dripped on her arm; A spontaneous report was received from a 45-year-old, female patient who is an occupational therapist who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced the event, incorrect dose administered. The patient's medical history was not provided. No relevant concomitant medications were reported. On 29 Dec 2020, the patient received their first of two planned doses of mRNA-1273 (Lot number:B11J20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection. On 29 Dec 2020, during the administration of the vaccine, the administrator used the pinch method and some of the vaccine leaked out and dripped on her arm. The reporter stated they are still determining if she received the full dose or less than the full dose. No treatment information was provided. Action taken with mRNA-1273 in response to the event was not reported. The event, incorrect dose administered, was considered resolved on 29 Dec 2020.; Reporter's Comments: This case concerns a 45-year-old female patient who received their first of two planned doses of mRNA-1273 (Lot B11J20A), reporting Incorrect dose administered without any associated adverse events.

Other Meds:

Current Illness:

ID: 0942584
Sex: U
Age:
State: WV

Vax Date: 12/29/2020
Onset Date: 12/29/2020
Rec V Date: 01/14/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Administered 1mL doses instead of 0.5mL dose; A spontaneous report was received from a nurse concerning a patient who received Moderna's COVID-19 vaccine (mRNA-1273) and was administered 1mL dose instead of 0.5mL dose. The patient's medical history was not provided. No relevant concomitant medications were reported. On 29 Dec 2020, the patient received their first of two planned doses of mRNA-1273 intramuscularly for prophylaxis of COVID-19 infection. On 29 Dec 2020, after vaccine administration, the nurse called to report that the patient had been administered a 1mL dose instead of 0.5mL dose of the vaccine. No side effects were reported due to the event. No treatment information was provided. Action taken with mRNA-1273 in response to the event was not reported. The event, administered 1mL dose instead of 0.5mL dose, was considered resolved on 29 Dec 2020.; Reporter's Comments: This case concerns a patient of unknown age and gender The patient's medical history is not provided. The patient experienced an unexpected event of inappropriate dose of vaccine administered (1ml instead of recommended 0.5ml). The event occurred on 29 Dec 2020 during the administration of first dose of mRNA-1273. The patient did not have any side effects. The sponsor considered the event as not related to mRNA-1273.

Other Meds:

Current Illness:

ID: 0942585
Sex: F
Age: 48
State: TX

Vax Date: 12/29/2020
Onset Date: 12/29/2020
Rec V Date: 01/14/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Device use issue; Needle popped off and some vaccine leaked on arm; A spontaneous report was received from a surgical technician who was a 48-year-old, female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced the needle popped off and some vaccine leaked on her arm and not sure if she got the full dose. The patient's medical history was not provided. No relevant concomitant medications were reported. On 29 Dec 2020, the patient received ther first of two planned doses of mRNA-1273 intramuscularly in her left arm for prophylaxis of COVID-19 infection. On 29 Dec 2020, during administration of the vaccine, the needle popped off and some of the vaccine leaked on her arm. She thought that the needle was not on tight and she was not sure if she got the full dose. There was no reaction on her arm and her healthcare provider was not aware of the incident. Her provider told her to come back for the second dose in one month. No treatment information was provided. Action taken with mRNA-1273 in response to the events was not reported. The events, the needle popped off and some vaccine leaked on her arm and not sure if she got the full dose, were resolved on 29 Dec 2020.; Reporter's Comments: This case concerns a 48 year old female subject who experienced an unexpected event of not sure if she got the full dose. The event occurred on 29 Dec 2020 during administration of the first dose of the mRNA-1273 vaccine . There were no reported AEs associated with this case of not sure if she got the full dose.

Other Meds:

Current Illness:

ID: 0942586
Sex: F
Age: 51
State: CT

Vax Date: 12/27/2020
Onset Date: 12/27/2020
Rec V Date: 01/14/2021
Hospital:

Lab Data:

Allergies:

Symptoms: complete paralysis on the left side of her body and felt like it was bell's palsy; complete paralysis of the left side of her body and felt like it was bell's palsy; forearm, thumb, and pointer finger feels tingly; can't get a grip on things; Chills; headache; A spontaneous report was received from a 51-year-old, female consumer, who was also the patient, who received Moderna's COVID-19 vaccine and experienced the events, complete paralysis on the left side of her body and felt like it was bell's palsy, forearm, thumb and pointer finger feels tingly, can't get a grip on things, chills, and headache. The patient reported a history of anaphylactic shock, but had not experienced an episode in about 10 years. Concomitant product use was not reported. On 27 Dec 2020, approximately two hours prior to the onset of the symptoms, the patient received their first of two planned doses of mRNA-1273 intramuscularly in the left arm for prophylaxis of COVID-19 infection. On 27 Dec 2020, about two hours after receiving the vaccine, the patient felt chills and had a headache. The patient went to sleep and woke up to complete paralysis on the left side of her body and felt like it was bell's palsy. Since 27 Dec 2020, the patient's forearm, thumb, and pointer finger have felt tingly and she can't get a grip on things. Treatment for the events included ibuprofen. Action taken with mRNA-1273 in response to the event was unknown. The events forearm, thumb and pointer finger feels tingly and can't get a grip on things were considered not resolved. The outcome for the events, complete paralysis on the left side of her body and felt like it was bell's palsy, chills, and headache was unknown.; Reporter's Comments: This case concerns a 51-year-old, female subject with medical history of anaphylactic shock, who experienced a serious, unexpected events of hemiplegia and facial paralysis; and non-serious, unexpected events of paresthesia, motor dysfunction; and non-serious, expected events of chills and headache. The events of hemiplegia, facial paralysis, paresthesia, and motor dysfunction occurred same day of mRNA-1273 (lot # unknown) administration. The event of chills and headache occurred 2 hours after the vaccine administration. Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 0942587
Sex: F
Age:
State:

Vax Date: 12/29/2020
Onset Date: 12/29/2020
Rec V Date: 01/14/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Person giving me the injection gave it to me in behind my arm, above elbow in the triceps area I know it was subQ; They said it was a 30 gauge needle; A spontaneous report was received from a female nurse who was also the patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and person giving me the injection gave it to me in behind my arm, above elbow in the triceps area I know it was subQ and they said it was a 30 gauge needle. The patient's medical history was not provided. No relevant concomitant medications were reported. On 29 Dec 2020, the patient received her first of two planned doses of mRNA-1273 subcutaneously in the arm for prophylaxis of COVID-19 infection. On 29 Dec 2020, the patient stated she was given the vaccine injection behind her arm, above the elbow, in the triceps area, subcutaneously. She was also suspicious of the size of the needle used. She was told it was a 30-gauge needle that was supplied by Moderna. The patient stated she was a nurse practitioner and had given over hundreds of injections during her career and was certain her injection was not intramuscular. No treatment information was provided. Action taken with mRNA-1273 in response to the events was not reported. The events, person giving me the injection gave it to me in behind my arm, above elbow in the triceps area I know it was subQ and they said it was a 30 gauge needle, were considered resolved on 29 Dec 2020.; Reporter's Comments: This case concerns a female patient who received their first of two planned doses of mRNA-1273 (Lot unknown), reporting Incorrect route of product administration and Drug administration in wrong device without any associated adverse events.

Other Meds:

Current Illness:

ID: 0942588
Sex: F
Age:
State: TN

Vax Date:
Onset Date:
Rec V Date: 01/14/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Bell's palsy; A spontaneous report was received from a nurse, who was a female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced Bell's palsy. The patient's medical history was not provided. No relevant concomitant medications were reported. On an unknown date, prior to the onset of the event, the patient received their first of two planned doses of mRNA-1273 intramuscularly for prophylaxis of COVID-19 infection. On an unknown date, within three days after vaccine administration, the reporter stated that she went to the doctor because she had problems with the whole left side of her face. The patient reported she has Bell's palsy now, she cannot smile. No treatment information was provided. Action taken with mRNA-1273 in response to the event was not reported. The outcome of event, Bell's palsy, was unknown. The reporter assessed the event, Bell's palsy, as related to mRNA-1273.; Reporter's Comments: This case concerns a female patient, who experienced a serious unexpected event of facial paralysis. The event of facial paralysis occurred approximately 3 days after the first dose of mRNA-1273 (Lot# unknown) administration. Very limited information regarding this event has been provided at this time. Based on temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 134,999

Page last modified: 14 December 2021 10:42pm